Clinical Trial Update: Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension [Phase 3]

View source ↗

Summary

Phase 3 factorial trial assessing Telmisartan and Ramipril for hypertension; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Ramipril (ramipril)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED